Callie Hall
Nurse Practitioner · Flowood, MSNPI 1083188387
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 413 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 413 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$908
- Abbott$748
- Boehringer Ingelheim$502
- Bayer$447
- Corcept Therapeutics$441
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $1,010 |
| Lilly USA, LLC | 62 | $908 |
| Abbott | 44 | $748 |
| Boehringer Ingelheim | 38 | $502 |
| Bayer | 29 | $447 |
| Corcept Therapeutics | 18 | $441 |
| AstraZeneca | 22 | $354 |
| Dexcom, Inc. | 21 | $342 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $312 |
| Amgen | 12 | $291 |
| Novartis | 15 | $246 |
| Merck | 11 | $213 |
| AbbVie | 13 | $199 |
| Amneal Pharmaceuticals LLC | 10 | $161 |
| Sanofi-aventis U.S. LLC | 7 | $106 |
| Radius Health, Inc. | 5 | $90 |
| Amarin Pharma, Inc. | 5 | $85 |
| Madrigal Pharmaceuticals | 3 | $78 |
| Esperion Therapeutics, Inc. | 4 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Tandem Diabetes Care, Inc. | 3 | $58 |
| Ascendis Pharma Endocrinology Inc | 3 | $54 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| IBSA Pharma Inc. | 3 | $43 |
| Recordati_rare_diseases_inc. | 3 | $41 |
| GSK | 2 | $40 |
| Tolmar, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| GRT US Holding, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$119
- DEXCOM G6 TRANSMITTER$112
- Korlym$104
How this compares
$7,092 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $57,720 |
| JardianceEmpagliflozin | 35 | $26,245 |
| MounjaroTirzepatide | 15 | $15,254 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 22 | $12,873 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 15 | $9,257 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $7,917 |
| SynthroidLevothyroxine Sodium | 15 | $1,032 |
| Glimepiride | 99 | $851 |
| Metformin Hcl | 38 | $169 |
| Rosuvastatin Calcium | 14 | $161 |
| Atorvastatin Calcium | 16 | $150 |
| Metformin Hcl ErMetformin Hcl | 19 | $127 |
| Amlodipine Besylate | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,010 | $57,72043 claims |
| Boehringer IngelheimJardiance | $502 | $26,24535 claims |
| Lilly USA, LLCMounjaro | $908 | $15,25415 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $106 | $9,25715 claims |
| AbbVieSynthroid | $199 | $1,03215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Flowood
- Sara KlausFlowood$48K
- Carmen CarrFlowood$6K
- Amanda SullivanFlowood$5K
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
- Jennifer HollyJackson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.